Privia Health Group Inc (PRVA) PT Lowered to $28 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
JPMorgan Positive on Privia Health Group Inc (PRVA) Following Earnings, Management Call
February 27, 2024 12:09 PM ESTJPMorgan analyst Lisa C. Gill reiterated an Overweight rating and $20.00 price target on Privia Health Group Inc (NASDAQ: PRVA)
The analyst comments "We are positive on PRVA as the companys notably more conservative and contrarian approach to capitated risk is driving greater financial... More
Privia Health Group, Inc. (PRVA) Tops Q4 EPS by 11c, provides guidance
February 27, 2024 6:15 AM ESTPrivia Health Group, Inc. (NASDAQ: PRVA) reported Q4 EPS of $0.15, $0.11 better than the analyst estimate of $0.04. Revenue for the quarter came in at $440.8 million versus the consensus estimate of $426.53 million.
GUIDANCE:
Privia Health Group, Inc. sees FY 2024 revenue of $1.6-1.675 billion,... More
